Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/5/e004965.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849764094725324800 |
|---|---|
| author | Bin Zhang Jieling Zheng |
| author_facet | Bin Zhang Jieling Zheng |
| author_sort | Bin Zhang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-0bd3905ec0234165bdb6e212cdcf1189 |
| institution | DOAJ |
| issn | 2051-1426 |
| language | English |
| publishDate | 2022-05-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj-art-0bd3905ec0234165bdb6e212cdcf11892025-08-20T03:05:14ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262022-05-0110510.1136/jitc-2022-004965Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et alBin Zhang0Jieling Zheng1Department of Radiology, Jinan University First Affiliated Hospital, Guangzhou, Guangdong, ChinaRadiology, Jinan University First Affiliated Hospital, Guangzhou, Guangdong, Chinahttps://jitc.bmj.com/content/10/5/e004965.full |
| spellingShingle | Bin Zhang Jieling Zheng Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al Journal for ImmunoTherapy of Cancer |
| title | Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al |
| title_full | Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al |
| title_fullStr | Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al |
| title_full_unstemmed | Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al |
| title_short | Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al |
| title_sort | correspondence on novel imaging biomarkers predict outcomes in stage iii unresectable non small cell lung cancer treated with chemoradiation and durvalumab by jazieh et al |
| url | https://jitc.bmj.com/content/10/5/e004965.full |
| work_keys_str_mv | AT binzhang correspondenceonnovelimagingbiomarkerspredictoutcomesinstageiiiunresectablenonsmallcelllungcancertreatedwithchemoradiationanddurvalumabbyjaziehetal AT jielingzheng correspondenceonnovelimagingbiomarkerspredictoutcomesinstageiiiunresectablenonsmallcelllungcancertreatedwithchemoradiationanddurvalumabbyjaziehetal |